INOVIO PHARMACEUTICALS, INC. Amortization of Intangible Assets
INOVIO PHARMACEUTICALS, INC. (INO) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-03-18
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2024-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2024-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2023 was $145.42K, a 70.71% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2022 was $496.49K, a 4.60% decline from fiscal 2021.
- INOVIO PHARMACEUTICALS, INC. amortization of intangible assets for fiscal 2021 was $520.41K, a 4.87% decline from fiscal 2020.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 10-K · filed 2025-03-18 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-03-18 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $0.00 derived: sum of 4 quarters · filed 2025-03-18 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $63.33K derived: sum of 4 quarters · filed 2025-03-18 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $63.33K derived: sum of 3 quarters · filed 2025-03-18 | $145.42K 10-K · filed 2025-03-18 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $63.33K derived: sum of 2 quarters · filed 2024-11-14 | $145.42K 10-Q · filed 2024-11-14 | $265.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $63.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $145.42K 10-Q · filed 2024-08-08 | $265.00K derived: sum of 3 quarters · filed 2024-08-08 | $385.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $82.08K 10-Q · filed 2024-05-13 | $201.67K derived: sum of 2 quarters · filed 2024-05-13 | $321.67K derived: sum of 3 quarters · filed 2024-05-13 | $452.67K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $119.58K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $239.58K derived: sum of 2 quarters · filed 2024-03-06 | $370.58K derived: sum of 3 quarters · filed 2024-03-06 | $496.49K 10-K · filed 2024-03-06 | |
| 2022-09-30 | $120.00K 10-Q · filed 2022-11-08 | $251.00K derived: sum of 2 quarters · filed 2022-11-08 | $376.91K 10-Q · filed 2023-11-09 | $504.54K derived: sum of 4 quarters · filed 2024-03-06 | |
| 2022-06-30 | $131.00K 10-Q · filed 2022-08-09 | $257.33K 10-Q · filed 2023-08-09 | $384.54K derived: sum of 3 quarters · filed 2024-03-06 | $511.54K derived: sum of 4 quarters · filed 2024-03-06 | |
| 2022-03-31 | $126.77K 10-Q · filed 2023-05-10 | $253.54K derived: sum of 2 quarters · filed 2024-03-06 | $380.54K derived: sum of 3 quarters · filed 2024-03-06 | $510.54K derived: sum of 4 quarters · filed 2024-03-06 | |
| 2021-12-31 | $126.77K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $253.77K derived: sum of 2 quarters · filed 2024-03-06 | $383.77K derived: sum of 3 quarters · filed 2024-03-06 | $520.41K 10-K · filed 2024-03-06 | |
| 2021-09-30 | $127.00K 10-Q · filed 2022-11-08 | $257.00K derived: sum of 2 quarters · filed 2022-11-08 | $393.64K 10-Q · filed 2022-11-08 | $530.54K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $130.00K 10-Q · filed 2022-08-09 | $266.87K 10-Q · filed 2022-08-09 | $403.54K derived: sum of 3 quarters · filed 2023-03-01 | $540.54K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $136.77K 10-Q · filed 2022-05-10 | $273.54K derived: sum of 2 quarters · filed 2023-03-01 | $410.54K derived: sum of 3 quarters · filed 2023-03-01 | $547.54K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $136.77K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $273.77K derived: sum of 2 quarters · filed 2023-03-01 | $410.77K derived: sum of 3 quarters · filed 2023-03-01 | $547.08K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $137.00K 10-Q · filed 2021-11-09 | $274.00K derived: sum of 2 quarters · filed 2021-11-09 | $410.31K 10-Q · filed 2021-11-09 | $677.38K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $137.00K 10-Q · filed 2021-08-09 | $273.54K 10-Q · filed 2021-08-09 | $540.38K derived: sum of 3 quarters · filed 2022-03-01 | $807.38K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $136.77K 10-Q · filed 2021-05-10 | $403.38K derived: sum of 2 quarters · filed 2022-03-01 | $670.38K derived: sum of 3 quarters · filed 2022-03-01 | $937.38K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $266.61K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $533.61K derived: sum of 2 quarters · filed 2022-03-01 | $800.61K derived: sum of 3 quarters · filed 2022-03-01 | $1.07M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $267.00K 10-Q · filed 2020-11-09 | $534.00K derived: sum of 2 quarters · filed 2020-11-09 | $799.69K 10-Q · filed 2020-11-09 | $1.07M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $267.00K 10-Q · filed 2020-08-10 | $533.13K 10-Q · filed 2020-08-10 | $800.13K derived: sum of 3 quarters · filed 2021-03-01 | $1.07M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $266.56K 10-Q · filed 2020-05-11 | $533.13K derived: sum of 2 quarters · filed 2021-03-01 | $800.13K derived: sum of 3 quarters · filed 2021-03-01 | $1.11M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $266.56K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $533.56K derived: sum of 2 quarters · filed 2021-03-01 | $845.56K derived: sum of 3 quarters · filed 2021-03-01 | $1.25M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $267.00K 10-Q · filed 2019-11-12 | $579.00K derived: sum of 2 quarters · filed 2019-11-12 | $983.02K 10-Q · filed 2019-11-12 | $1.39M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | $312.00K 10-Q · filed 2019-08-08 | $716.46K 10-Q · filed 2019-08-08 | $1.12M derived: sum of 3 quarters · filed 2020-03-12 | $1.52M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | $404.06K 10-Q · filed 2019-05-09 | $808.13K derived: sum of 2 quarters · filed 2020-03-12 | $1.21M derived: sum of 3 quarters · filed 2020-03-12 | $1.62M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | $404.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $808.06K derived: sum of 2 quarters · filed 2020-03-12 | $1.21M derived: sum of 3 quarters · filed 2020-03-12 | $1.62M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $404.00K 10-Q · filed 2018-11-08 | $808.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.21M 10-Q · filed 2018-11-08 | $1.62M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-06-30 | $404.00K 10-Q · filed 2018-08-07 | $810.54K 10-Q · filed 2018-08-07 | $1.22M derived: sum of 3 quarters · filed 2019-03-12 | $1.63M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-03-31 | $406.30K 10-Q · filed 2018-05-09 | $814.78K derived: sum of 2 quarters · filed 2019-03-12 | $1.23M derived: sum of 3 quarters · filed 2019-03-12 | $1.57M derived: sum of 4 quarters · filed 2019-03-12 | |
| 2016-12-31 | $408.48K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $820.48K derived: sum of 2 quarters · filed 2019-03-12 | $1.17M derived: sum of 3 quarters · filed 2019-03-12 | $1.38M 10-K · filed 2019-03-12 | |
| 2016-09-30 | $412.00K 10-Q · filed 2017-11-08 | $759.00K derived: sum of 2 quarters · filed 2017-11-08 | $968.99K 10-Q · filed 2017-11-08 | $1.18M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | $347.00K 10-Q · filed 2017-08-08 | $556.55K 10-Q · filed 2017-08-08 | $768.69K derived: sum of 3 quarters · filed 2018-03-14 | $983.69K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | $209.54K 10-Q · filed 2017-05-10 | $421.69K derived: sum of 2 quarters · filed 2018-03-14 | $636.69K derived: sum of 3 quarters · filed 2018-03-14 | $855.69K derived: sum of 4 quarters · filed 2018-03-14 | |
| 2015-12-31 | $212.15K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $427.15K derived: sum of 2 quarters · filed 2018-03-14 | $646.15K derived: sum of 3 quarters · filed 2018-03-14 | $870.20K 10-K · filed 2018-03-14 | |
| 2015-09-30 | $215.00K 10-Q · filed 2016-11-09 | $434.00K derived: sum of 2 quarters · filed 2016-11-09 | $658.05K 10-Q · filed 2016-11-09 | $888.08K derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | $219.00K 10-Q · filed 2016-08-08 | $442.62K 10-Q · filed 2016-08-08 | $673.08K derived: sum of 3 quarters · filed 2017-03-15 | $908.08K derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-03-31 | $223.49K 10-Q · filed 2016-05-09 | $454.08K derived: sum of 2 quarters · filed 2017-03-15 | $689.08K derived: sum of 3 quarters · filed 2017-03-15 | $927.08K derived: sum of 4 quarters · filed 2017-03-15 | |
| 2014-12-31 | $230.60K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $465.60K derived: sum of 2 quarters · filed 2017-03-15 | $703.60K derived: sum of 3 quarters · filed 2017-03-15 | $942.72K 10-K · filed 2017-03-15 | |
| 2014-09-30 | $235.00K 10-Q · filed 2015-11-09 | $473.00K derived: sum of 2 quarters · filed 2015-11-09 | $712.12K 10-Q · filed 2015-11-09 | $1.15M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | $238.00K 10-Q · filed 2015-08-10 | $477.46K 10-Q · filed 2015-08-10 | $915.67K derived: sum of 3 quarters · filed 2016-03-14 | $1.36M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $239.81K 10-Q · filed 2015-05-11 | $677.67K derived: sum of 2 quarters · filed 2016-03-14 | $1.12M derived: sum of 3 quarters · filed 2016-03-14 | $1.56M derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | $437.86K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $877.86K derived: sum of 2 quarters · filed 2016-03-14 | $1.32M derived: sum of 3 quarters · filed 2016-03-14 | $1.77M 10-K · filed 2016-03-14 | |
| 2013-09-30 | $440.00K 10-Q · filed 2014-11-10 | $885.00K derived: sum of 2 quarters · filed 2014-11-10 | $1.33M 10-Q · filed 2014-11-10 | $1.78M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-06-30 | $445.00K 10-Q · filed 2014-08-11 | $893.03K 10-Q · filed 2014-08-11 | $1.34M derived: sum of 3 quarters · filed 2015-03-16 | $1.80M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-03-31 | $447.93K 10-Q · filed 2014-05-12 | $898.35K derived: sum of 2 quarters · filed 2015-03-16 | $1.35M derived: sum of 3 quarters · filed 2015-03-16 | $1.81M derived: sum of 4 quarters · filed 2015-03-16 | |
| 2012-12-31 | $450.43K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $903.43K derived: sum of 2 quarters · filed 2015-03-16 | $1.36M derived: sum of 3 quarters · filed 2015-03-16 | $1.82M 10-K · filed 2015-03-16 | |
| 2012-09-30 | $453.00K 10-Q · filed 2013-11-12 | $466.00K 10-Q · filed 2012-11-07 | $910.00K derived: sum of 2 quarters · filed 2013-11-12 | $1.37M 10-Q · filed 2013-11-12 | $1.83M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $457.00K 10-Q · filed 2013-08-09 | $917.37K 10-Q · filed 2013-08-09 | $1.38M derived: sum of 3 quarters · filed 2014-03-17 | $1.83M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2012-03-31 | $460.62K 10-Q · filed 2013-05-10 | $923.31K derived: sum of 2 quarters · filed 2014-03-17 | $1.38M derived: sum of 3 quarters · filed 2014-03-17 | $1.85M derived: sum of 4 quarters · filed 2014-03-17 | |
| 2011-12-31 | $462.69K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $915.69K derived: sum of 2 quarters · filed 2014-03-17 | $1.38M derived: sum of 3 quarters · filed 2014-03-17 | $1.87M 10-K · filed 2014-03-17 | |
| 2011-09-30 | $453.00K 10-Q · filed 2012-11-07 | $922.00K derived: sum of 2 quarters · filed 2012-11-07 | $1.41M 10-Q · filed 2012-11-07 | $1.87M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $469.00K 10-Q · filed 2012-08-09 | $940.57K 10-Q · filed 2012-08-09 | $1.42M derived: sum of 3 quarters · filed 2013-03-18 | $1.89M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $471.48K 10-Q · filed 2012-05-09 | $946.37K derived: sum of 2 quarters · filed 2013-03-18 | $1.42M derived: sum of 3 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $474.89K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $953.46K derived: sum of 2 quarters · filed 2013-03-18 | $1.91M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $478.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.44M 10-Q · filed 2011-11-07 | |||
| 2010-06-30 | $960.45K 10-Q · filed 2011-08-05 | ||||
| 2009-12-31 | $1.44M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |